期刊文献+

氯硝柳胺磷酸酯通过抑制Wnt/β-catenin通路抑制肾脏组织纤维化

Phosphate niclosamide mitigates renal fibrosis through inhibiting Wnt/β-catenin signaling pathway
下载PDF
导出
摘要 目的探讨氯硝柳胺磷酸酯(P-NICLO)抑制肾脏组织纤维化的作用及其可能机制。方法构建体内试验(UUO模型)及体外实验(TGF-β1体外刺激NRK-52E细胞导致细胞转分化)模型,予以一定浓度P-NICLO干预,然后通过病理染色,Western blot及Real-time PCR等生物信息学方法,检测P-NICLO对不同模型组肾脏组织纤维化的抑制作用及其对Wnt/β-catenin信号通路的影响。结果体内及体外实验均表明,P-NICLO可以明显抑制模型组肾脏组织纤维化,模型组Wnt/β-catenin信号通路也被明显抑制,差异有统计学意义(P<0.05)。结论 P-NICLO可能通过抑制Wnt/β-catenin信号通路而抑制肾脏组织纤维化。 Objective To explore the effect of p-niclosamide(P-NICLO)on renal fibrosis and its possible mechanism.Methods In vivo experiments(UUO model)and in vitro experiments(TGF-β1 stimulated NRK-52E cells in vitro),models were given P-NICLO intervention at a certain concentration to detect the inhibitory effect of P-NICLO on renal fibrosis in different model groups and its effect on Wnt/β-catenin signaling pathway by pathological staining,Western blot and Real-time PCR.Results Both in vivo and in vitro experiments showed that P-NICLO could significantly inhibit renal fibrosis and Wnt/β-catenin signaling pathway in model group.Conclusion P-NICLO may mitigate renal fibrosis through inhibiting the Wnt/β-catenin signaling pathway.
作者 常晓燕 吴启美 江肖 吴永贵 Chang Xiaoyan;Wu Qimei;Jiang Xiao(Dept of Nephrology,The First Affiliated Hospital of Anhui Medical University,Hefei 230022)
出处 《安徽医科大学学报》 CAS 北大核心 2018年第10期1538-1543,共6页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金青年基金(编号:81700606)
关键词 P-NICLO 肾脏纤维化 WNT/Β-CATENIN P-NICLO renal fibrosis Wnt/β-catenin
  • 相关文献

参考文献1

二级参考文献17

  • 1Weinbach EC,Garbus J.Mechanism of action of reagents that uncouple oxidative phosphorylation.Nature,1969,221:1016-1018.
  • 2Jin Y,Lu Z,Ding K,et al.Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells:inactivation of the NF-kappa B pathway and generation of reactive oxygen species.Cancer Res,2010,70:2516-2527.
  • 3OsadaT,Chen M,Yang XY,et al.Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations.Cancer Res,2011,71:4172-4182.
  • 4Sack U,Walther W,Scudiero D,et al.Novel effect of antihelminthic niclosamide on S100A4-mediated metastatic progression in colon cancer.J Natl Cancer Inst,2011,103:1018-1036.
  • 5Ren XM,Duan L,He Q,et al.Identification of niclosamide as a new small-molecule inhibitor of the STAT3signaling pathway.ACS Med Chem Lett,2010,1:454-459.
  • 6Grum-Schwensen B,Klingelhofer J,Berg CH,et al.Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1)gene.Cancer Res,2005,65:3772-3780.
  • 7O’Brien CA,Kreso A,Jamieson CH.Cancer stem cells and self-renewal.Clin Cancer Res,2010,16:3113-3120.
  • 8Wang AM,Ku HH,Liang YC,et al.The autonomous notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562cells.J Cell Biochem,2009,106:682-692.
  • 9Chen F,Castranova V.Nuclear factor-kappaB,an unappreciated tumor suppressor.Cancer Res,2007,67:11093-11098.
  • 10C Wang,Deng L,Hong M,et al.TAK1is a ubiquitin-dependent kinase of MKK and IKK.Nature,2001,412:346-351.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部